133 related articles for article (PubMed ID: 10596904)
1. Pharmacological modulation of nitric oxide synthesis by mechanism-based inactivators and related inhibitors.
Bryk R; Wolff DJ
Pharmacol Ther; 1999 Nov; 84(2):157-78. PubMed ID: 10596904
[TBL] [Abstract][Full Text] [Related]
2. Selective pharmacological inhibition of distinct nitric oxide synthase isoforms.
Southan GJ; Szabó C
Biochem Pharmacol; 1996 Feb; 51(4):383-94. PubMed ID: 8619882
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform.
Szabó C; Bryk R; Zingarelli B; Southan GJ; Gahman TC; Bhat V; Salzman AL; Wolff DJ
Br J Pharmacol; 1996 Aug; 118(7):1659-68. PubMed ID: 8842429
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of nitric oxide synthases and cellular nitric oxide formation by N6-iminoethyl-L-lysine and N5-iminoethyl-L-ornithine.
Wolff DJ; Lubeskie A; Gauld DS; Neulander MJ
Eur J Pharmacol; 1998 Jun; 350(2-3):325-34. PubMed ID: 9696424
[TBL] [Abstract][Full Text] [Related]
5. Cellular and enzymatic studies of N(omega)-propyl-l-arginine and S-ethyl-N-[4-(trifluoromethyl)phenyl]isothiourea as reversible, slowly dissociating inhibitors selective for the neuronal nitric oxide synthase isoform.
Cooper GR; Mialkowski K; Wolff DJ
Arch Biochem Biophys; 2000 Mar; 375(1):183-94. PubMed ID: 10683266
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of inactivation of inducible nitric oxide synthase by amidines. Irreversible enzyme inactivation without inactivator modification.
Zhu Y; Nikolic D; Van Breemen RB; Silverman RB
J Am Chem Soc; 2005 Jan; 127(3):858-68. PubMed ID: 15656623
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous rearrangement of aminoalkylisothioureas into mercaptoalkylguanidines, a novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform.
Southan GJ; Zingarelli B; O'Connor M; Salzman AL; Szabó C
Br J Pharmacol; 1996 Feb; 117(4):619-32. PubMed ID: 8646406
[TBL] [Abstract][Full Text] [Related]
8. Human dermal fibroblasts produce nitric oxide and express both constitutive and inducible nitric oxide synthase isoforms.
Wang R; Ghahary A; Shen YJ; Scott PG; Tredget EE
J Invest Dermatol; 1996 Mar; 106(3):419-27. PubMed ID: 8648170
[TBL] [Abstract][Full Text] [Related]
9. The antithyroid agent 6-n-propyl-2-thiouracil is a mechanism-based inactivator of the neuronal nitric oxide synthase isoform.
Wolff DJ; Marks N
Arch Biochem Biophys; 2002 Nov; 407(1):83-94. PubMed ID: 12392718
[TBL] [Abstract][Full Text] [Related]
10. Rat myometrial smooth muscle cells express endothelial nitric oxide synthase.
Gangula PR; Dong YL; Yallampalli C
Hum Reprod; 1997 Mar; 12(3):561-8. PubMed ID: 9130760
[TBL] [Abstract][Full Text] [Related]
11. Aminoguanidine is an isoform-selective, mechanism-based inactivator of nitric oxide synthase.
Wolff DJ; Lubeskie A
Arch Biochem Biophys; 1995 Jan; 316(1):290-301. PubMed ID: 7530937
[TBL] [Abstract][Full Text] [Related]
12. Inactivation and recovery of nitric oxide synthetic capability in cytokine-induced RAW 264.7 cells treated with "irreversible" NO synthase inhibitors.
Wolff DJ; Lubeskie A; Li C
Arch Biochem Biophys; 1997 Feb; 338(1):73-82. PubMed ID: 9015390
[TBL] [Abstract][Full Text] [Related]
13. Estrogen induces nitric oxide production via activation of constitutive nitric oxide synthases in human neuroblastoma cells.
Xia Y; Krukoff TL
Endocrinology; 2004 Oct; 145(10):4550-7. PubMed ID: 15242984
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of nitric oxide synthase isoforms by diaminoguanidine and NG-amino-L-arginine.
Wolff DJ; Lubeskie A
Arch Biochem Biophys; 1996 Jan; 325(2):227-34. PubMed ID: 8561501
[TBL] [Abstract][Full Text] [Related]
15. Studies of neuronal nitric oxide synthase inactivation by diverse suicide inhibitors.
Bryk R; Lubeskie A; Wolff DJ
Arch Biochem Biophys; 1999 Sep; 369(2):243-51. PubMed ID: 10486143
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of inducible nitric oxide synthase exacerbates erosive joint disease.
McCartney-Francis NL; Song X; Mizel DE; Wahl SM
J Immunol; 2001 Feb; 166(4):2734-40. PubMed ID: 11160339
[TBL] [Abstract][Full Text] [Related]
17. Role of nitric-oxide synthase isoforms in nitrous oxide antinociception in mice.
Ishikawa M; Quock RM
J Pharmacol Exp Ther; 2003 Aug; 306(2):484-9. PubMed ID: 12721331
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic manipulation of nitric oxide signaling: targeting NOS dimerization and protein-protein interactions.
Paige JS; Jaffrey SR
Curr Top Med Chem; 2007; 7(1):97-114. PubMed ID: 17266598
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of trans 3,4-cyclopropyl L-arginine analogues as isoform selective inhibitors of nitric oxide synthase.
Fishlock D; Perdicakis B; Montgomery HJ; Guillemette JG; Jervis E; Lajoie GA
Bioorg Med Chem; 2003 Mar; 11(6):869-73. PubMed ID: 12614872
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of nitric oxide synthase by substituted aminoguanidines and aminoisothioureas.
Wolff DJ; Gauld DS; Neulander MJ; Southan G
J Pharmacol Exp Ther; 1997 Oct; 283(1):265-73. PubMed ID: 9336332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
